ICCCNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31

IMMUCELL CORP /DE/

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$10.51−0.24 (-2.23%)

Close on Oct 19, 2026

Market cap: $96.58M
P/E (TTM): 131.4
Dividend yield: –

IMMUCELL CORP /DE/ balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Cash & Equivalents	3.81	3.76	0.98	5.79	10	6.95	6.29	2.52	3.80	5.15	1.57	0.85	2.27	2.67	0.78	1.40	0.98	1.20
Short-Term Investments	–	–	–	–	–	1.00	2.48	–	–	5.47	4.47	2.49	2.99	2.24	4.18	3.23	–	–
Cash & Short-Term Investments	3.81	3.76	0.98	5.79	10	7.95	8.77	2.52	3.80	11	6.04	3.34	5.26	4.91	4.96	4.63	0.98	1.20
Receivables	3.42	3.77	2.19	1.76	2.69	1.80	1.64	0.93	1.34	0.99	0.72	1.01	0.63	0.61	0.35	0.47	–	–
Inventory	9.27	7.11	7.81	6.04	3.09	2.09	2.52	2.33	2.05	2.13	0.87	0.95	1.21	1.65	1.67	1.60	–	–
Prepaid Expenses & Other	0.45	0.40	0.49	0.41	0.30	0.32	0.26	0.64	0.31	0.60	0.25	0.15	0.16	0.16	0.08	0.24	–	–
Other Current Assets	–	–	0.06	0.08	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Current Assets	17	15	11	14	16	12	13	6.42	7.51	14	7.88	5.47	7.27	7.36	7.15	6.97	–	–
Property, Plant & Equipment	21	25	28	28	27	27	25	26	26	9.85	5.72	3.84	2.52	2.36	2.52	2.71	–	–
Gross Property, Plant & Equipment	40	46	46	44	41	38	35	33	32	15	10	8.28	6.54	6.18	5.95	–	–	–
Accumulated Depreciation	-19	-21	-18	-16	-14	-12	-9.61	-7.42	-5.94	-5.45	-4.75	-4.45	-4.01	-3.82	-3.43	–	–	–
Land	–	–	–	–	–	–	–	–	–	0.35	0.33	0.05	0.05	0.05	0.05	–	–	–
Buildings & Improvements	–	–	–	–	–	–	–	–	–	5.04	4.72	2.97	2.94	2.79	2.67	–	–	–
Machinery & Equipment	–	–	–	–	–	–	–	–	–	5.56	3.77	3.52	3.18	3.03	2.98	–	–	–
Construction in Progress	–	–	–	–	–	–	–	–	–	3.69	1.08	1.27	0.01	0	0.00	–	–	–
Long-Term Investments	–	–	–	–	–	–	–	–	–	–	0.49	0.50	0	–	–	–	–	–
Operating Lease Right-of-Use Assets	4.38	4.56	4.57	2.19	1.11	1.22	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0	–	–	–	–	–	–	–
Intangible Assets	0	0.02	0.04	0.06	0.08	0.10	0.11	0.13	0.15	0.17	0	–	–	–	–	–	–	–
Deferred Tax Assets	–	–	–	–	–	–	–	–	0.47	0.20	0.45	1.23	1.15	1.25	1.31	1.04	–	–
Other Long-Term Assets	0.04	0.03	0.06	14	0.03	0.03	0.03	0.01	0.00	0.03	0	0.02	0.01	0.06	0.02	0.03	–	–
Total Assets	43	45	44	45	44	40	39	33	34	25	15	11	11	11	11	11	–	–
Accounts Payable	2.28	2.48	2.12	2.00	1.61	1.35	1.22	1.22	1.72	1.89	0.66	0.85	0.45	0.23	0.15	0.11	–	–
Accrued Expenses	–	–	–	–	–	–	–	–	–	–	–	–	0.29	0.26	0.30	0.37	–	–
Short-Term Debt	–	–	10	8.90	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Current Portion of Long-Term Debt	1.61	1.50	1.43	1.04	–	–	8.52	9.38	9.09	–	–	–	–	–	–	–	–	–
Current Debt	1.61	1.50	12	9.94	–	–	8.52	9.38	9.09	–	–	–	–	–	–	–	–	–
Current Portion of Leases	0.09	0.43	0.64	0.03	0.11	0.10	–	–	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	0.01	0.01	0.00	0.00	0.00	–	–	–	–	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	–	–	–	–	–	–	–	–	0.02	0.03	0	0.01	0	0	0.01	0	–	–
Total Current Liabilities	3.98	4.41	4.20	3.07	2.53	2.21	2.50	2.57	2.06	2.06	0.79	1.01	0.64	0.67	0.64	0.53	–	–
Long-Term Debt	7.49	9.04	11	9.19	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Long-Term Leases	4.01	4.13	4.08	2.22	1.03	1.14	–	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	4.10	4.56	4.72	2.25	0.16	1.24	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	15	18	19	14	12	12	9.70	11	11	4.98	3.93	1.79	1.56	1.84	1.97	1.47	–	–
Total Debt	9.10	11	22	19	–	–	8.52	9.38	9.09	–	–	–	–	–	–	–	–	–
Common Stock	0.91	0.90	0.78	0.78	0.78	0.73	0.73	0.57	0.57	0.50	0.33	0.33	0.33	0.33	0.33	0.33	–	–
Additional Paid-In Capital	41	41	36	36	36	31	31	23	22	19	10	10	10	9.97	9.91	9.78	–	–
Retained Earnings	-15	-14	-12	-6.23	-3.74	-3.66	-2.64	-1.34	0.98	1.15	0.64	-0.57	-0.41	-0.52	-0.61	-0.20	–	–
Treasury Stock	-0.13	-0.14	-0.14	-0.15	-0.16	-0.18	-0.19	-0.20	-0.41	-0.43	-0.45	-0.51	-0.51	-0.53	-0.56	-0.63	–	–
Comprehensive Income & Other	–	–	–	–	–	–	-0.04	0.03	0.00	-0.02	-0.05	-0.02	-0.02	-0.05	-0.04	0.01	–	–
Shareholders' Equity	27	28	25	30	33	28	29	22	24	20	11	9.26	9.40	9.19	9.02	9.28	9.62	9.64
Total Equity	27	28	25	30	33	28	29	22	24	20	11	9.26	9.40	9.19	9.02	9.28	9.62	9.64
Total Liabilities & Equity	43	45	44	45	44	40	39	33	34	25	15	11	11	11	11	11	–	–
Shares Outstanding(shares)	9.05	8.98	7.75	7.75	7.74	7.22	7.21	5.57	5.48	4.85	3.06	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 40.3%
Operating margin: 12.6%
Net margin: 2.6%
Return on equity, FY2025: -3.8%

Financial strength

Current ratio: 4.75
Debt to equity: 0.26
Debt to assets: 17.8%
Cash to current liabilities: 199.7%

Valuation

P/E ratio: 131.4
Price to sales: 3.15
Price to book: 3.08
Dividend yield: –